Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome
Author(s) -
Manfredi Tesauro,
Francesca Schinzari,
Micaela Iantorno,
Stefano Rizza,
D Melina,
Davide Lauro,
Carmine Cardillo
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.105.553883
Subject(s) - ghrelin , medicine , endocrinology , sodium nitroprusside , vasodilation , nitric oxide , endothelial dysfunction , acetylcholine , endothelium , metabolic syndrome , saline , hormone , obesity
Metabolic syndrome importantly accelerates the atherosclerotic process, the earliest event of which is endothelial dysfunction. Ghrelin, a gastric peptide with cardiovascular actions, has been shown to inhibit proatherogenic changes in experimental models. This study therefore investigated whether ghrelin administration might beneficially affect endothelial function in metabolic syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom